Photocatalytic removal of antacid histamine H2-receptor antagonist Ranitidine

被引:0
|
作者
Jain, Rajeev [1 ]
Goyal, Swati [1 ]
Kadam, Satyendra [1 ]
机构
[1] Jiwaji Univ, Dept Chem, Gwalior 474011, Madhya Pradesh, India
关键词
Photocatalytic degradation; Ranitidine; kinetic study; TiO2; UV; H2O2; AQUATIC ENVIRONMENT; PESTICIDE DERIVATIVES; HUMAN PHARMACEUTICALS; AQUEOUS SUSPENSIONS; ORGANIC POLLUTANTS; THERAPEUTIC DRUGS; DEGRADATION; TIO2; PHOTODEGRADATION; OXIDATION;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In the present study photocatalytic degradation of an antacid histamine H2-receptor antagonist Ranitidine with TiO2 as photocatalyst under UV irradiation in aqueous solution has been investigated. The efficiency of degradation was optimized by several parameters such as effect of initial concentration, catalyst loading, pH, temperature, irradiation time and addition of H2O2 as a co-oxidant. On optimization of various parameters it was found that almost complete degradation of Ranitidine by TiO2 could be achieved within 70 min for an initial concentration of 0.20 mg/mL of the drug and at a catalyst loading of 0.06 g/L. Study on the effect of electron acceptors reveals that both decolourisation and degradation increase in the presence of the electron acceptor. The maximum degradation efficiency of Ranitidine was achieved with the combination of UV + H2O2 + TiO2 and the optimum concentration of the H2O2 is 0.003 mM. The decolourisation and degradation kinetics was found to follow first-order kinetics according to the Langmuir-Hinshelwood (L-H) model. The activated energy for the photocatalytic degradation of Ranitidine is 21.28 kJ/mol. Over all photocatalytic degradation of Ranitidine by TiO2 is an effective, economic and faster mode of removing Ranitidine from aqueous solution.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 50 条
  • [31] Interaction of the new histamine H2-receptor antagonist pibutidine hydrochloride with canine cloned H2-receptor expressed cells
    Kaku, S
    Isobe, Y
    Kiuchi, Y
    Tanaka, M
    Muramatsu, M
    Higuchi, S
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1999, 49 (01): : 67 - 71
  • [32] INHIBITION OF GASTRIC-SECRETION IN MAN WITH A NEW H2-RECEPTOR ANTAGONIST, RANITIDINE
    KETT, K
    AADLAND, E
    BERSTAD, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1980, 15 (02) : 249 - 251
  • [33] PLACENTAL-TRANSFER OF THE H2-RECEPTOR ANTAGONIST RANITIDINE (R) IN THE PREGNANT SHEEP
    MIHALY, GW
    MORGAN, DJ
    MARSHALL, AW
    COCKBAIN, S
    SMALLWOOD, RA
    HARDY, KJ
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (06) : 619 - 620
  • [34] EFFECTS OF RANITIDINE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST, ON HISTAMINE-INDUCED AND ASPIRIN-INDUCED GASTRIC-ULCERS IN RATS AND DOGS
    OKABE, S
    TABATA, K
    OHTSUKI, H
    FOLIA PHARMACOLOGICA JAPONICA, 1981, 78 (06) : 549 - 555
  • [35] Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist
    Takahashi, Morio
    Katayama, Yasumi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1493 - 1497
  • [36] THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST RANITIDINE - DURATION OF ACTION
    DAMMANN, HG
    SIMON, B
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1981, 16 : 39 - 43
  • [37] HISTAMINE AND H2-RECEPTOR ANTAGONISTS
    LORENZ, W
    THERAPIE DER GEGENWART, 1977, 116 (09): : 1624 - &
  • [38] THE NEW HISTAMINE H-2-RECEPTOR ANTAGONIST RANITIDINE - DURATION OF ACTION
    DAMMANN, HG
    MULLER, P
    KATHER, H
    SIMON, B
    RESEARCH IN EXPERIMENTAL MEDICINE, 1981, 178 (02) : 151 - 154
  • [39] HISTAMINE H2-RECEPTOR ANTAGONISTS
    SEWING, KF
    ACTA HEPATO-GASTROENTEROLOGICA, 1976, 23 (03): : 221 - 226
  • [40] HISTAMINE H2-RECEPTOR ANTAGONISTS
    GANELLIN, CR
    DURANT, GJ
    EMMETT, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1974, : 37 - 37